85 related articles for article (PubMed ID: 35045669)
1. [Clinical characteristics and prognosis of patients with Waldenström macroglobulinemia and its comparison with the Pivotal study].
Tao Y; Wang S; Wang L; Wu M; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):993-997. PubMed ID: 35045669
[No Abstract] [Full Text] [Related]
2. [Exploring the detection of MYD88 mutation in patients with Waldenström macroglobulinemia by different methods and specimens].
Tao Y; Pan ZK; Wang S; Wang L; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2022 May; 43(5):388-392. PubMed ID: 35680596
[No Abstract] [Full Text] [Related]
3. [Diagnosis and treatment understanding of Waldenström macroglobulinemia in China: a cross-sectional study].
Yi SH; Xiong WJ; Cao XX; Sun CY; Du J; Wang HH; Wang L; Niu T; Jiang ZX; Wei YQ; Xue H; Chu HL; Qiu LG; Li J
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):148-155. PubMed ID: 38604791
[No Abstract] [Full Text] [Related]
4. Current approach to Waldenström macroglobulinemia.
Kapoor P; Rajkumar SV
Blood Rev; 2023 Nov; 62():101129. PubMed ID: 37659912
[TBL] [Abstract][Full Text] [Related]
5. Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects.
Ghafoor B; Masthan SS; Hameed M; Akhtar HH; Khalid A; Ghafoor S; Allah HM; Arshad MM; Iqbal I; Iftikhar A; Husnain M; Anwer F
Ann Hematol; 2024 Jun; 103(6):1859-1876. PubMed ID: 37414960
[TBL] [Abstract][Full Text] [Related]
6. Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis.
Cao X; Ye Q; Orlowski RZ; Wang X; Loghavi S; Tu M; Thomas SK; Shan J; Li S; Qazilbash M; Yin CC; Weber D; Miranda RN; Xu-Monette ZY; Medeiros LJ; Young KH
J Hematol Oncol; 2015 Jun; 8():74. PubMed ID: 26104577
[TBL] [Abstract][Full Text] [Related]
7. Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia.
Tawfiq RK; Abeykoon JP; Kapoor P
Curr Hematol Malig Rep; 2024 Mar; ():. PubMed ID: 38536576
[TBL] [Abstract][Full Text] [Related]
8. Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients.
D'Sa S; Matous JV; Advani R; Buske C; Castillo JJ; Gatt M; Kapoor P; Kersten MJ; Leblond V; Leiba M; Palomba ML; Paludo J; Qiu L; Sarosiek S; Shadman M; Talaulikar D; Tam CS; Tedeschi A; Thomas SK; Tohidi-Esfahani I; Trotman J; Varettoni M; Vos J; Garcia-Sanz R; San-Miguel J; Dimopoulos MA; Treon SP; Kastritis E
Semin Hematol; 2023 Mar; 60(2):80-89. PubMed ID: 37147252
[TBL] [Abstract][Full Text] [Related]
9. Waldenström Macroglobulinemia: Review of Pathogenesis and Management.
Yun S; Johnson AC; Okolo ON; Arnold SJ; McBride A; Zhang L; Baz RC; Anwer F
Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):252-262. PubMed ID: 28366781
[TBL] [Abstract][Full Text] [Related]
10. MYD88-independent growth and survival effects of Sp1 transactivation in Waldenstrom macroglobulinemia.
Fulciniti M; Amodio N; Bandi RL; Munshi M; Yang G; Xu L; Hunter Z; Tassone P; Anderson KC; Treon SP; Munshi NC
Blood; 2014 Apr; 123(17):2673-81. PubMed ID: 24622324
[TBL] [Abstract][Full Text] [Related]
11. Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia.
Yu Y; Xiong W; Wang T; Yan Y; Lyu R; Wang Q; Liu W; An G; Sui W; Xu Y; Huang W; Zou D; Wang J; Qiu L; Yi S
Blood Sci; 2024 Jan; 6(1):e00179. PubMed ID: 38239572
[TBL] [Abstract][Full Text] [Related]
12. Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia.
Chen J; Jia MN; Cai H; Li ZP; Li J; Zhou DB; Cao XX
Ann Hematol; 2024 Mar; ():. PubMed ID: 38448788
[TBL] [Abstract][Full Text] [Related]
13. Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study.
Jeong S; Kong SG; Kim DJ; Lee S; Lee HS
BMC Cancer; 2020 Jul; 20(1):623. PubMed ID: 32620091
[TBL] [Abstract][Full Text] [Related]
14. New developments in the management of Waldenström macroglobulinemia.
Abeykoon JP; Yanamandra U; Kapoor P
Cancer Manag Res; 2017; 9():73-83. PubMed ID: 28331368
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis.
Bai SJ; He JX; Zheng YJ; Geng Y; Gao YN; Zhang CX; Wang YR; Qin LY; Wang WJ; Yang LH
Ann Hematol; 2024 May; ():. PubMed ID: 38761184
[TBL] [Abstract][Full Text] [Related]
16. Waldenström Macroglobulinemia-Associated Peripheral Neuropathy in the Brachial Plexus With Bing-Neel Syndrome Diagnosed Through Repeated Cerebrospinal Tests.
Hatasa M; Imoto N; Komori S; Nosaki Y; Kurahashi S
Cureus; 2024 Jan; 16(1):e52400. PubMed ID: 38361676
[TBL] [Abstract][Full Text] [Related]
17. IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM.
Bazarbachi AH; Avet-Loiseau H; Szalat R; Samur AA; Hunter Z; Shammas M; Corre J; Fulciniti M; Anderson KC; Parmigiani G; Treon SP; Mohty M; Munshi NC; Samur MK
Blood; 2021 Nov; 138(20):1980-1985. PubMed ID: 34792571
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003.
Dhodapkar MV; Hoering A; Gertz MA; Rivkin S; Szymonifka J; Crowley J; Barlogie B
Blood; 2009 Jan; 113(4):793-6. PubMed ID: 18931340
[TBL] [Abstract][Full Text] [Related]
19. High efficacy of CD19 CAR T-cells in patients with transformed Waldenström macroglobulinemia.
Durot E; Roosweil D; Chauchet A; Decroocq J; Di Blasi R; Gastinne T; Bensaber H; Cheminant M; Jacquet C; Guidez S; Gros FX; Bachy E; Coste A; Cony-Makhoul P; Treon SP; Delmer AJ; Reshef R; Le Gouill S; Castillo JJ; Houot R
Blood; 2024 Apr; ():. PubMed ID: 38669635
[TBL] [Abstract][Full Text] [Related]
20. Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital.
Danesin N; Lo Schirico M; Scapinello G; Grassi A; Riva M; Berno T; Branca A; Visentin A; Carraro M; Pavan L; Manni S; Bonaldi L; Martines A; Bertorelle R; Vianello F; Gurrieri C; Briani C; Zambello R; Trentin L; Piazza F
Hemasphere; 2023 Oct; 7(10):e964. PubMed ID: 37799344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
